Parkinson's disease and dementia with Lewy bodies: a difference in dose?
暂无分享，去创建一个
[1] David W. Miller,et al. α-Synuclein in blood and brain from familial Parkinson disease with SNCA locus triplication , 2004, Neurology.
[2] A. Singleton,et al. The law of mass action applied to neurodegenerative disease: a hypothesis concerning the etiology and pathogenesis of complex diseases. , 2004, Human molecular genetics.
[3] Matthew J. Farrer,et al. Comparison of kindreds with parkinsonism and α‐synuclein genomic multiplications , 2004 .
[4] Janel O. Johnson,et al. α-Synuclein Locus Triplication Causes Parkinson's Disease , 2003, Science.
[5] R. Nussbaum,et al. Effect of allelic variation at the NACP-Rep1 repeat upstream of the alpha-synuclein gene (SNCA) on transcription in a cell culture luciferase reporter system. , 2001, Human molecular genetics.
[6] Matthew J. Farrer,et al. α-synuclein gene haplotypes are associated with Parkinson’s disease , 2001 .
[7] H Okazaki,et al. Hereditary form of parkinsonism—dementia , 1998, Annals of neurology.
[8] Olaf Riess,et al. AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease , 1998, Nature Genetics.
[9] M. L. Schmidt,et al. α-Synuclein in Lewy bodies , 1997, Nature.
[10] Robert L. Nussbaum,et al. Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .